216 related articles for article (PubMed ID: 14730629)
1. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide.
Chiba A; Oki S; Miyamoto K; Hashimoto H; Yamamura T; Miyake S
Arthritis Rheum; 2004 Jan; 50(1):305-13. PubMed ID: 14730629
[TBL] [Abstract][Full Text] [Related]
2. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis.
Kaieda S; Tomi C; Oki S; Yamamura T; Miyake S
Arthritis Rheum; 2007 Jun; 56(6):1836-45. PubMed ID: 17530712
[TBL] [Abstract][Full Text] [Related]
3. The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine models.
Chiba A; Kaieda S; Oki S; Yamamura T; Miyake S
Arthritis Rheum; 2005 Jun; 52(6):1941-8. PubMed ID: 15934073
[TBL] [Abstract][Full Text] [Related]
4. Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramide.
Togashi Y; Chamoto K; Wakita D; Tsutsumi N; Iwakura Y; Matsubara N; Kitamura H; Nishimura T
Cancer Sci; 2007 May; 98(5):721-5. PubMed ID: 17359285
[TBL] [Abstract][Full Text] [Related]
5. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway.
Miellot A; Zhu R; Diem S; Boissier MC; Herbelin A; Bessis N
Eur J Immunol; 2005 Dec; 35(12):3704-13. PubMed ID: 16304639
[TBL] [Abstract][Full Text] [Related]
6. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice.
Mizuno M; Masumura M; Tomi C; Chiba A; Oki S; Yamamura T; Miyake S
J Autoimmun; 2004 Dec; 23(4):293-300. PubMed ID: 15571923
[TBL] [Abstract][Full Text] [Related]
7. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
Mauri C; Feldmann M; Williams RO
Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production.
Lo CK; Lam QL; Sun L; Wang S; Ko KH; Xu H; Wu CY; Zheng BJ; Lu L
Arthritis Rheum; 2008 Sep; 58(9):2700-11. PubMed ID: 18759269
[TBL] [Abstract][Full Text] [Related]
10. Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs.
Chu CQ; Londei M
J Immunol; 1996 Sep; 157(6):2685-9. PubMed ID: 8805674
[TBL] [Abstract][Full Text] [Related]
11. Preferential T(h)2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo.
Oki S; Tomi C; Yamamura T; Miyake S
Int Immunol; 2005 Dec; 17(12):1619-29. PubMed ID: 16291659
[TBL] [Abstract][Full Text] [Related]
12. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.
Hong S; Wilson MT; Serizawa I; Wu L; Singh N; Naidenko OV; Miura T; Haba T; Scherer DC; Wei J; Kronenberg M; Koezuka Y; Van Kaer L
Nat Med; 2001 Sep; 7(9):1052-6. PubMed ID: 11533710
[TBL] [Abstract][Full Text] [Related]
13. NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production.
Kim HY; Kim HJ; Min HS; Kim S; Park WS; Park SH; Chung DH
J Exp Med; 2005 Jan; 201(1):41-7. PubMed ID: 15630137
[TBL] [Abstract][Full Text] [Related]
14. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
Bharhani MS; Chiu B; Na KS; Inman RD
Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
[TBL] [Abstract][Full Text] [Related]
15. Pivotal advance: alpha-galactosylceramide induces protection against lipopolysaccharide-induced shock.
Sireci G; La Manna MP; Di Sano C; Di Liberto D; Porcelli SA; Kronenberg M; Dieli F; Salerno A
J Leukoc Biol; 2007 Mar; 81(3):607-22. PubMed ID: 17046969
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
[TBL] [Abstract][Full Text] [Related]
17. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.
Miyamoto K; Miyake S; Yamamura T
Nature; 2001 Oct; 413(6855):531-4. PubMed ID: 11586362
[TBL] [Abstract][Full Text] [Related]
18. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
Yanagisawa K; Exley MA; Jiang X; Ohkochi N; Taniguchi M; Seino K
Cancer Res; 2006 Dec; 66(23):11441-6. PubMed ID: 17145891
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
20. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]